salary: Her total remuneration package rose to 5.89m in 2018, from 4.88m the previous year, Britain's biggest drugmaker revealed in its annual report, according to The Guardian. Her fixed pay salary, benefits and pension rose slightly to 1.47m, while Walmsley's performance-related pay annual bonus and shares awarded under the company's long-term incentive scheme increased to 4.42m from 3.45m. Walmsley is thought to be the highest-paid female chief executive of a FTSE 100 company at present. Emma Walmsley profile from marketing at L'Or al to GSK chief Read more Late last year, GSK announced plans for a breakup with the spin-off of its consumer healthcare business, in a 10bn joint venture with US rival Pfizer. It was her first full year at the helm, after takingover from Sir Andrew Witty in April 2017, having previously run the consumer healthcare division. It was one of several deals overseen by Walmsley in 2018, when the company's profits before tax rose 36% to 4.8bn.
(news.financializer.com). As
reported in the news.
Tagged under salary, scheme topics.